QualityStocksNewsBreaks Archives - Page 664 of 1524

TuesdaySep 28, 2021 10:25 am

QualityStocksNewsBreaks – DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF) Subsidiary Subject of Broadcast Featuring ETPs on Frankfurt Exchange

DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF), a digital asset investment firm bridging the gap between traditional capital markets and decentralized finance, is the featured company in a recent NetworkNewsAudio (“NNA”) broadcast. The broadcast spotlights the recent announcement by DeFi Technologies subsidiary Valour regarding imminent listing of its Exchange Traded Products (“ETPs”) on the Frankfurt Stock Exchange. The company is slated to begin trading on Oct. 1, 2021, and will trade in Bitcoin Zero and Ethereum Zero. The 12th largest exchange in the world, the Frankfurt Stock Exchange is the largest of seven regional securities exchanges in Germany.…

TuesdaySep 28, 2021 10:11 am

QualityStocksNewsBreaks – Delic Holdings Inc.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Meet Delic to Showcase Lamar Odom’s Path to Healing with Psychedelics

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), the leading psychedelic wellness platform, today announced that two-time NBA champion Lamar Odom will headline Meet Delic on Nov. 7, 2021. Odom’s professional basketball career spanned 15 years, including seven as a forward with the Los Angeles Lakers that earned him 2009 and 2010 NBA championships. Odom joined LeBron James, Allen Iverson, Tim Duncan and Dwayne Wade as members of the gold-winning U.S. men’s basketball team at the 2004 Athens Olympics. In 2015, Odom was hospitalized in Las Vegas after a near-death overdose resulting in multiple seizures, strokes and a coma. An upcoming documentary…

MondaySep 27, 2021 2:37 pm

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Announces Launch of the ‘Desire Project’

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE”), a leader in advanced proprietary technology and research in psychedelics, today unveiled its “Desire Project,” a clinical research program focused on the treatment of female hypoactive sexual desire disorder with MDMA-assisted psychotherapy. According to the update, the research program will mark the first psychedelic-based treatment program targeted at addressing what is clinically known as Hypoactive Sexual Desire Disorder (“HSDD”), a common sexual disorder characterized by persistent low sexual desire and emotional distress not attributable to an existing medical condition or relationship issue. Current estimates indicate that HSDD affects 10% of…

MondaySep 27, 2021 2:09 pm

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE), Mullen Automotive Inc. Release Update Letter to Shareholders

Mullen Automotive, an emerging electric vehicle manufacturer, which previously announced a definitive stock-for-stock reverse merger agreement with Net Element (NASDAQ: NETE), in which Mullen’s stockholders will receive a majority of the outstanding stock in the post-merger company, today released a letter to shareholders from Mullen’s CEO David Michery. “As we begin the fourth quarter of 2021, I would like to take this opportunity to update everyone on the progress being made to complete the merger with Net Element. I am pleased to say that the SEC has declared effective the S-4 registration statement of the shares of the merger. The shareholders…

MondaySep 27, 2021 1:45 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Launches Keef Beverages in Ontario Through the OCS

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, today announced the shipment of its award-winning Keef Brands cannabis-infused beverages to the Ontario Cannabis Store (“OCS”). According to the update, the Keef products will be available in Ontario retail locations across the province and online at OCS.ca in October 2021. The products are also expected to hit British Columbia and Alberta shelves by early November 2021. “We’re very excited to launch these top-selling and highly anticipated beverages in Ontario through the OCS,” said BevCanna’s President Melise Panetta. “The OCS is the largest…

MondaySep 27, 2021 1:24 pm

QualityStocksNewsBreaks – Ideanomics Inc. (NASDAQ: IDEX), Subsidiaries Slated to Present Solutions During Upcoming Sustainable Fleet Technology Conference

Ideanomics (NASDAQ: IDEX), a global company focused on driving the adoption of commercial electric vehicles and associated energy consumption, will be participating in the monthlong, all-virtual Sustainable Fleet Technology (“SFT”) Conference. The conference is designed to showcase the “latest and greatest” in sustainable fleet tech, operations and implementations. The conference takes place twice a week — Tuesday and Thursdays — from 2–3:30 p.m. EST, and runs through Oct. 19, 2021. Ideanomics, along with its subsidiaries WAVE and US Hybrid, will be participating in panel discussions scheduled for Sept. 30, Oct. 12 and Oct. 14. IDEX chief scientist and US Hybrid CEO…

MondaySep 27, 2021 1:07 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Eyes Commercial Plans to Become B2B Wholesale Supplier of Rare Cannabinoids

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company based in British Columbia, Canada, is focused on advancing a pipeline of cannabinoid-based pharmaceutical drug candidates. The company is developing a proprietary cannabinoid synthesis manufacturing system known as IntegraSyn(TM), which is designed to advance rare and lesser-known cannabinoid production to commercial levels. A recent article discussing this quotes InMed CEO Eric A. Adams. “The next key milestone is to manufacture our first large-scale batch through a pharma-grade-ready process in the coming months. We will continue to optimize the process and scale up the IntegraSyn process into larger vessels,” Adams said in a recent…

MondaySep 27, 2021 12:52 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Completes First Step in European Expansion Plan

Flora Growth Corp. (NASDAQ: FLGC) recently closed a €2 million investment in Hoshi International Inc., a fully integrated cannabis company, and uniquely positioned to become the leading provider of cannabis and derivative products for the budding European market. With the investment, Flora is set to capitalize on Hoshi’s strong European presence as well as leverage its technical know-how and understanding of its European market to not only expand its reach but also obtain its European Union Good Manufacturing Practices (“EU-GMP”) certification. A recent article reads, “Flora hopes to capitalize on Hoshi’s understanding of and presence within the European market to…

MondaySep 27, 2021 12:34 pm

QualityStocksNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Enters Strategic Commercial Agreement with UK Licensee

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced its entry into a global commercial contract with MySugarWatch DuoPack Limited (“MSW-DP”). Under the agreement, the continuous glucose monitor (“CGM”) and sensors will be provided as duo packs with prescription only medicines that are widely prescribed for people with type 2 diabetes. MSW-DP has been granted global rights to the sugarBEAT(R) non-invasive CGM devices and sensors, to be provided solely as duo packs with these medicines, under the terms of the agreement, which Nemaura will…

MondaySep 27, 2021 11:56 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Working to Bring Psychedelic Treatments Closer to the People

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is contributing to the ongoing conversation around the use of psychedelics in the field of medicine, thereby stamping its position as a leader in the psychedelic renaissance. This follows efforts by the scientific community in the 21st century to prove the potential of psychedelics to rewire or repair circuits in the brain. Specifically, Tryp is bringing light to psilocybin usage in diseases with high unmet needs, including chronic pain, through its Psilocybin-For Neuropsychiatric Disorders (TM) (“PFN”) program. “With its three strategic initiatives — develop, protect and monetize — Tryp remains committed to utilizing FDA’s…

Site Search

Company Search

Category: QualityStocksNewsBreaks